LONDON (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new diabetes drug from Bristol-Myers Squibb and AstraZeneca in some circumstances, marking a change of tack following an earlier blanket rejection. The National Insti...
Source: http://health.yahoo.net/news/s/nm/nice-backs-astra-bristol-diabetes-drug-in-some-cases
for more more information more info info
No comments:
Post a Comment
Note: only a member of this blog may post a comment.